Why the study?
Does aspirin prevent cardiovascular events in a primary prevention setting?
Does aspirin prevent cardiovascular events in a primary prevention setting?
This document provides the USPSTF recommendations on using aspirin for the primary prevention of cardiovascular events.
Answers are grounded in this paper and cite their sources.
Shapes aspirin prescribing in primary prevention; extends RCT evidence into updated clinical guidance.
This statement summarizes the recommendation of the third U.S. Preventive Services Task Force (USPSTF) for aspirin for the primary prevention of cardiovascular events, as well as the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, can be found in a companion article in this issue. Copies of this document, the summary of the evidence, and the systematic evidence review can be obtained through the USPSTF Web site (http://www.ahrq.gov/clinic/uspstfix.htm) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295).
No takes yet. Share an insight, caveat, or question.
A 2002 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: